Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
challenging, rewarding, exciting, collaborative, meaningful
O que você mais gosta nos lideres?
Passion, Courage, Commitment, Intellect and Innovation
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
fast paced, constantly challenged, celebrate victories
Qual é a melhor parte das suas compensações?
base, bonus and equity with monthly vesting after year 1
O que faz você mais feliz no trabalho?
Moving the company, the science and the function forward every day. Putting patients first
Quais são algumas das melhores coisas da sua equipe?
We have each others backs and we actually care about each other as people. We also have diverse and complimentary skills.
Other Employee Reviews for Karyopharm Therapeutics
×